Literature DB >> 21870060

Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

Cheuk-Kit Wong1, Harvey D White.   

Abstract

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is an enzyme which binds to oxidized LDL and has a pro-inflammatory role in the pathogenesis of atherosclerosis. The Lp-PLA(2) Studies Collaboration showed the relationship between Lp-PLA(2) levels and activity with coronary heart disease and ischemic stroke. Levels and activity of Lp-PLA(2) are reduced by statins. There have been limited studies focused on dietary factors and effects on LpPLA(2). A recent article from the Nurses' Health Study (HNS) and the Health Professionals Follow-up Study (HPFS) has provided interesting insights. In this cross sectional study, a lower LpPLA(2) activity was found to be related to several dietary factors including higher percentage of energy consumed as protein instead of carbohydrate, mild to moderate intake of alcohol, higher mono-unsaturated fat intake instead of carbohydrate, and not being overweight. It is unknown whether changes in Lp-PLA(2) by diet alter cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21870060     DOI: 10.1007/s11883-011-0201-4

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  24 in total

Review 1.  The role of lipoprotein-associated phospholipase a₂ as a marker and potential therapeutic target in atherosclerosis.

Authors:  Ralph A H Stewart; Harvey D White
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

Review 2.  Effects of ethanol intake on lipoproteins and atherosclerosis.

Authors:  Eliot A Brinton
Journal:  Curr Opin Lipidol       Date:  2010-08       Impact factor: 4.776

3.  Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects.

Authors:  Ernst J Schaefer; Judith R McNamara; Bela F Asztalos; Timothy Tayler; Jennifer A Daly; Joi L Gleason; Leo J Seman; Andrea Ferrari; Joel J Rubenstein
Journal:  Am J Cardiol       Date:  2005-05-01       Impact factor: 2.778

4.  Ergosterol peroxide from flowers of Erigeron annuus L. as an anti-atherosclerosis agent.

Authors:  Dong-Hyun Kim; Sung Je Jung; In-Sik Chung; Youn-Hyung Lee; Dae-Keun Kim; Sung-Hoon Kim; Byoung-Mog Kwon; Tae-Sook Jeong; Mi-Hyun Park; Nak-Sul Seoung; Nam-In Baek
Journal:  Arch Pharm Res       Date:  2005-05       Impact factor: 4.946

5.  The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study.

Authors:  Joseph B Muhlestein; Heidi T May; Jonathan R Jensen; Benjamin D Horne; Richard B Lanman; Farangis Lavasani; Robert L Wolfert; Robert R Pearson; H Daniel Yannicelli; Jeffrey L Anderson
Journal:  J Am Coll Cardiol       Date:  2006-05-24       Impact factor: 24.094

6.  The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort.

Authors:  Margaretha Persson; Jan-Ake Nilsson; Jeanenne J Nelson; Bo Hedblad; Göran Berglund
Journal:  Atherosclerosis       Date:  2006-03-13       Impact factor: 5.162

7.  Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women.

Authors:  T Tzotzas; T D Filippatos; A Triantos; E Bruckert; A D Tselepis; D N Kiortsis
Journal:  Nutr Metab Cardiovasc Dis       Date:  2007-10-10       Impact factor: 4.222

8.  The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults.

Authors:  Maria Weinkouff Pedersen; Wolfgang Koenig; Jeppe Hagstrup Christensen; Erik Berg Schmidt
Journal:  Eur J Nutr       Date:  2008-11-21       Impact factor: 5.614

9.  Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.

Authors:  Shahar Lavi; Joseph P McConnell; Charanjit S Rihal; Abhiram Prasad; Verghese Mathew; Lilach O Lerman; Amir Lerman
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

10.  Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.

Authors:  Ida J Hatoum; Jeanenne J Nelson; Nancy R Cook; Frank B Hu; Eric B Rimm
Journal:  Am J Clin Nutr       Date:  2010-01-27       Impact factor: 7.045

View more
  1 in total

1.  Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients.

Authors:  Joshua S Wooten; Preethi Nambi; Baiba K Gillard; Henry J Pownall; Ivonne Coraza; Lynne W Scott; Vijay Nambi; Christie M Ballantyne; Ashok Balasubramanyam
Journal:  Med Sci Sports Exerc       Date:  2013-06       Impact factor: 5.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.